ENTELLIGENCETM Program
ENTELLIGENCE is a program for clinical and basic science research in the field of cardiopulmonary medicine. The program provides opportunities for individual young investigators to promote quality medical care and enhance patients' lives by supporting research in pulmonary hypertension (PH) related to expanding our knowledge of the pathways involved in pulmonary vascular pathobiology. ENTELLIGENCE is led by a Steering Committee comprised of leaders in the field of PH. Investigator-initiated trials for young researchers will be supported if they are conducted at universities and research institutes in the United States and Canada.
More about ENTELLIGENCE »
Young Investigators Award Application Submission
The ENTELLIGENCE Young Investigators Award Program provides a total of 5 grants of $100,000 each to qualified investigators to conduct research via a 12-month mentored grant. Grants are awarded by the Steering Committee based on scientific merit, originality, feasibility, and applicability to the problem of pulmonary hypertension.
Application Guidelines »
Previous Award Winners
Established in 2005, the Young Investigators Award Program has funded more than 20 promising researchers in the field of pulmonary hypertension.
More about previous award winners »
The ENTELLIGENCETM program is supported through an educational grant from Actelion Pharmaceuticals US, Inc. ENTELLIGENCE is run as a nonprofit program.